Methods and Compositions for Treating Wounds and Reducing the Risk of Incisional Hernias
AssigneeThe Regents of the University of California
InventorHobart W. Harris
Life of this patent
Estimating the term…
Abstract
Provided are methods and compositions for treating a wound in a subject. The methods include applying a pharmaceutical composition that includes a first precursor material agent including fibrinogen, a second precursor material agent including thrombin, and silver particles to an abdominal incision site in an amount effective to treat the abdominal incision site. Also provided are pharmaceutical compositions and devices for use in the subject methods.
Claims20
A method for treating a wound in a subject, the method comprising:
- applying a pharmaceutical composition comprising a first precursor material agent comprising fibrinogen, a second precursor material agent comprising thrombin, and silver particles to an abdominal incision site in an amount effective to treat the abdominal incision site.
A pharmaceutical composition for treating a wound in a subject, the composition comprising:
- a fibrin glue and silver particles in an amount effective to treat an abdominal incision site.
A device for applying a pharmaceutical composition for treating a wound in a subject, the device comprising:
- a sterile container containing a first precursor material agent comprising fibrinogen, a second precursor material agent comprising thrombin, and silver particles in an amount effective to treat an abdominal incision site.
A kit comprising:
- a sterile container containing a first precursor material agent comprising fibrinogen, a second precursor material agent comprising thrombin, and silver particles in an amount effective to treat an abdominal incision site;
- and
- a sealed package configured to maintain the sterility of the sterile container.
Dependencies are inferred from the claim text.